Jan 29 (Reuters) - Leeâ€™s Pharmaceutical Holdings Ltd :
* CHINA FDA GRANTS UNIT APPROVAL FOR CLINICAL TRIALS FOR ITS RECOMBINANT HUMAN ANTI-PD-L1 MONOCLONAL ANTIBODY INJECTION Source text for Eikon: Further company coverage:
 